| scholarly article | Q13442814 |
| P50 | author | David K. Shay | Q38641565 |
| Stephanie A. Irving | Q43089463 | ||
| Edward A Belongia | Q59829972 | ||
| Burney A Kieke | Q94540662 | ||
| Jennifer K Meece | Q114338925 | ||
| P2093 | author name string | Allen C Bateman | |
| P2860 | cites work | Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities | Q28741469 |
| Humoral and cell-mediated immunity to pandemic H1N1 influenza in a Canadian cohort one year post-pandemic: implications for vaccination | Q28742312 | ||
| Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial. | Q30383723 | ||
| Effectiveness of seasonal influenza vaccine against pandemic (H1N1) 2009 virus, Australia, 2010 | Q30404923 | ||
| Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis | Q30408691 | ||
| Safety and long-term humoral immune response in adults after vaccination with an H1N1 2009 pandemic influenza vaccine with or without AS03 adjuvant. | Q30412748 | ||
| Comparison of the long-term immunogenicity of two pandemic influenza A/H1N1 2009 vaccines, the MF59-adjuvanted and unadjuvanted vaccines, in adults | Q30413670 | ||
| Measuring disease frequency in the Marshfield Epidemiologic Study Area (MESA) | Q33723434 | ||
| Efficacy studies of influenza vaccines: effect of end points used and characteristics of vaccine failures | Q34754945 | ||
| Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group | Q40625504 | ||
| Long-term immunogenicity of influenza vaccine among the elderly: Risk factors for poor immune response and persistence | Q43174206 | ||
| Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults | Q44300971 | ||
| Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results | Q45848424 | ||
| Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season | Q46159620 | ||
| A solution to the problem of separation in logistic regression. | Q52942642 | ||
| What Does the Odds Ratio Estimate in a Case-Control Study? | Q57153184 | ||
| Evaluation of self-reported and registry-based influenza vaccination status in a Wisconsin cohort | Q57384993 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pandemic | Q12184 |
| influenza vaccine | Q383260 | ||
| influenza A virus | Q834390 | ||
| P304 | page(s) | 1262-1269 | |
| P577 | publication date | 2013-01-22 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season | |
| P478 | volume | 207 |
| Q42241105 | A one-step RT-PCR array for detection and differentiation of zoonotic influenza viruses H5N1, H9N2, and H1N1. |
| Q42145296 | Concurrent and cross-season protection of inactivated influenza vaccine against A(H1N1)pdm09 illness among young children: 2012-2013 case-control evaluation of influenza vaccine effectiveness |
| Q53283393 | Does consecutive influenza vaccination reduce protection against influenza: A systematic review and meta-analysis. |
| Q30391150 | Effect of Statin Use on Influenza Vaccine Effectiveness |
| Q34033876 | Effectiveness of 2012-2013 influenza vaccine against influenza-like illness in general population: estimation in a French web-based cohort |
| Q30367263 | Effectiveness of pandemic and seasonal influenza vaccines in preventing laboratory-confirmed influenza in adults: a clinical cohort study during epidemic seasons 2009-2010 and 2010-2011 in Finland. |
| Q30355688 | Immunogenicity and safety of an inactivated 2012/2013 trivalent influenza vaccine produced in mammalian cell culture (Optaflu®): an open label, uncontrolled study. |
| Q30391418 | Infant Respiratory Outcomes Associated with Prenatal Exposure to Maternal 2009 A/H1N1 Influenza Vaccination |
| Q40644474 | Influenza vaccine effectiveness: Maintained protection throughout the duration of influenza seasons 2010-2011 through 2013-2014. |
| Q30359268 | Interim estimates of 2013-14 seasonal influenza vaccine effectiveness - United States, February 2014. |
| Q42237299 | Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada s sentinel surveillance network, January 2014. |
| Q30373642 | Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children. |
| Q38907201 | Observational studies and the difficult quest for causality: lessons from vaccine effectiveness and impact studies |
| Q34778408 | Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review |
| Q90692852 | The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology |
| Q38803189 | Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies |
Search more.